iC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma and Neuroblastoma
Clinical trial NCT01953900 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01953900
- Sponsor
- Baylor College of Medicine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2019-10-31
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.